glp 1 receptor agonist moa GLP-1 agonists in the treatment of type 2 diabetes – state-of-the-art GLP-1 receptor agonists for individualized
Description
Diabetes 63 , 407409 (2014)
For many people in recovery from opioid addiction, the combination of medication, therapy, and peer support through NA meetings make lasting recovery possible
2015;4:e9
L.StanwoodG
This is exciting because while presently there are already 3 FDA approved medications for alcohol use disorder, their effects are modest
That conceptual shift has profound implications for how these drugs are prescribed, evaluated, and reimbursed
